Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep383 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2017

Role of lactate dehydrogenase-A (LDH-A) in atherosclerosis

Park Keun Gyu , Choi Yeon Kyung , Bae Kwi Hyun , Seo Jung Beom

Pathological proliferation and migration of vascular smooth muscle cells (VSMCs) has been implicated in the pathogenesis of accelerated atherosclerosis in patients with diabetes mellitus. Increased aerobic glycolysis is a key feature of cellular phenotypes including cancer and immune cells. However, it remains largely unknown about the role of aerobic glycolysis in atherogenic phenotype of VSMCs. Here, we investigated the role of lactate dehydrogenase-A (LDH-A), which is a key...

ea0049gp56 | Cardiovascular & Lipid Endocrinology | ECE2017

PCSK9 in relation to coronary damage severity in patients with cardiovascular disease

Bae Kwi Hyun , Jung Gwon Soo , Kim Mi Jin , Choi Yeon Kyung , Seo Jung Beom , Park Keun Gyu

Proprotein convertase subtilisin/kexin type 9 (PCSK9), a circulating protein that promotes degradation of the low density lipoprotein (LDL) receptor, has been emerged as a novel therapeutic target for the dyslipidemia. It is well known that the pathogenesis of cardiovascular disease (CVD) involves lipid metabolism alteration, but the predictive value of circulating PCSK9 level concerning coronary disease severity is largely unknown. The main objective of this study is to deter...

ea0049ep506 | Diabetes complications | ECE2017

A protective effect of lobeglitazone on renal fibrosis in unilateral ureteral obstruction mice model

Kim Hye-Soon , Bae Kwi Hyun , Jung Gwon Soo , Ham Hye Jin , Park Bo Yoon , Choi Yeon Kyung , Seo hyun Ae , Seo Jung Beom , Park Keun Gyu

Renal tubulointerstitial fibrosis is a common feature of the final stage of nearly all cause types of chronic kidney disease. Although classic peroxisome proliferator-activated receptor-gamma (PPARĪ³) agonists have a protective effect on diabetic nephropathy, much less is known about their direct effects in renal fibrosis. This study aimed to investigate possible beneficial effects of lobeglitazone, a novel PPARĪ³ agonist, on renal fibrosis in mice with unilateral uret...